Christopher Mccourt

NPI: 1376994475
Total Payments
$4,701
2024 Payments
$1,939
Companies
23
Transactions
229
Medicare Patients
288
Medicare Billing
$33,390

Payment Breakdown by Category

Food & Beverage$4,624 (98.4%)
Education$77.49 (1.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,624 226 98.4%
Education $77.49 3 1.6%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $999.14 52 $0 (2024)
Lundbeck LLC $554.53 31 $0 (2024)
Otsuka America Pharmaceutical, Inc. $517.79 24 $0 (2024)
ITI, Inc. $365.58 11 $0 (2023)
Alkermes, Inc. $281.21 14 $0 (2024)
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $273.63 10 $0 (2024)
E.R. Squibb & Sons, L.L.C. $224.60 6 $0 (2024)
Axsome Therapeutics, Inc. $215.23 10 $0 (2024)
Sunovion Pharmaceuticals Inc. $205.57 13 $0 (2022)
Neurocrine Biosciences, Inc. $183.95 12 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,939 92 ABBVIE INC. ($340.63)
2023 $829.38 44 Lundbeck LLC ($174.57)
2022 $924.43 47 ABBVIE INC. ($302.09)
2021 $1,008 46 AbbVie Inc. ($318.64)

All Payment Transactions

229 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
12/19/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $19.26 General
Category: Psychology/Psychiatric
12/17/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $12.94 General
Category: NEUROSCIENCE
12/12/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $23.99 General
Category: NEUROSCIENCE
12/05/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $27.05 General
Category: PSYCHIATRY
12/04/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $25.52 General
Category: PSYCHIATRY
11/27/2024 Bausch Health US, LLC APLENZIN (Drug) Food and Beverage In-kind items and services $22.99 General
Category: Neurology
11/26/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $19.67 General
Category: Psychiatry/Psychology
11/26/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $6.97 General
Category: NEUROSCIENCE
11/21/2024 Alkermes, Inc. LYBALVI (Drug), LYBALVI, LYBALVI Food and Beverage In-kind items and services $28.47 General
Category: CNS
11/21/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $13.10 General
Category: Psychiatry/Psychology
11/19/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $23.92 General
Category: Central Nervous System
11/14/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $125.40 General
Category: Psychiatry/Psychology
11/14/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $18.80 General
Category: PSYCHIATRY
11/11/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $8.16 General
Category: NEUROSCIENCE
11/07/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $17.71 General
Category: Psychiatry/Psychology
11/05/2024 Tris Pharma Inc Dyanavel XR (Drug) Food and Beverage In-kind items and services $16.51 General
Category: ADHD
11/01/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $19.59 General
Category: VILOXAZINE HYDROCHLORIDE
10/31/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $10.86 General
Category: NEUROSCIENCE
10/30/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $18.06 General
Category: PSYCHIATRY
10/29/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $21.45 General
Category: Psychiatry/Psychology
10/22/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $15.69 General
Category: Central Nervous System
10/17/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $29.80 General
Category: PSYCHIATRY
10/15/2024 Vanda Pharmaceuticals Inc. HETLIOZ (Drug), FANAPT Food and Beverage In-kind items and services $34.31 General
Category: NON-24-HOUR SLEEP-WAKE DISORDER
10/09/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Education In-kind items and services $27.27 General
Category: Psychiatry/Psychology
10/04/2024 Bausch Health US, LLC APLENZIN (Drug) Food and Beverage In-kind items and services $16.80 General
Category: Neurology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 36 130 $17,999 $6,977
2022 3 103 180 $17,962 $7,679
2021 3 92 234 $22,743 $11,299
2020 2 57 159 $17,103 $7,434
Total Patients
288
Total Services
703
Medicare Billing
$33,390
Procedure Codes
10

All Medicare Procedures & Services

10 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 18 64 $10,440 $4,347 41.6%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2023 18 66 $7,559 $2,631 34.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 41 58 $8,130 $3,344 41.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 39 87 $7,434 $2,963 39.9%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2022 23 35 $2,398 $1,372 57.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 45 111 $9,630 $4,690 48.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 29 70 $9,455 $4,344 45.9%
90833 Psychotherapy performed with evaluation and management visit, 30 minutes Office 2021 18 53 $3,658 $2,265 61.9%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 38 127 $12,543 $5,424 43.2%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 19 32 $4,560 $2,010 44.1%

About Christopher Mccourt

Christopher Mccourt is a Family healthcare provider based in Wooster, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2016. The National Provider Identifier (NPI) number assigned to this provider is 1376994475.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Mccourt has received a total of $4,701 in payments from pharmaceutical and medical device companies, with $1,939 received in 2024. These payments were reported across 229 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($4,624).

As a Medicare-enrolled provider, Mccourt has provided services to 288 Medicare beneficiaries, totaling 703 services with total Medicare billing of $33,390. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Location Wooster, OH
  • Active Since 06/29/2016
  • Last Updated 07/21/2022
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • NPI Number 1376994475

Products in Payments

  • VRAYLAR (Drug) $999.14
  • CAPLYTA (Drug) $639.21
  • REXULTI (Drug) $561.16
  • ABILIFY MAINTENA (Drug) $323.68
  • ARISTADA (Drug) $224.65
  • COBENFY (Drug) $224.60
  • Auvelity (Drug) $215.23
  • LATUDA (Drug) $205.57
  • INGREZZA (Drug) $183.95
  • BRINTELLIX (Drug) $117.96
  • TRINTELLIX (Drug) $83.36
  • Austedo XR (Drug) $80.50
  • AZSTARYS (Drug) $67.73
  • SPRAVATO (Drug) $64.27
  • APLENZIN (Drug) $59.18
  • LYBALVI (Drug) $56.56
  • Qelbree (Drug) $56.35
  • Dyanavel XR (Drug) $51.72
  • INVEGA SUSTENNA (Drug) $50.19
  • ABILIFY ASIMTUFII (Drug) $45.85

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Wooster